T. Rowe Price Associates’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $288M | Sell |
|
|||||
|
2025
Q1 | $835M | Buy |
|
|||||
|
2024
Q4 | $481M | Sell |
|
|||||
|
2024
Q3 | $776M | Buy |
|
|||||
|
2024
Q2 | $619M | Buy |
|
|||||
|
2024
Q1 | $150M | Buy |
|
|||||
|
2023
Q4 | $154M | Buy |
|
|||||
|
2023
Q3 | $114M | Buy |
|
|||||
|
2023
Q2 | $104M | Buy |
|
|||||
|
2023
Q1 | $87M | Sell |
|
|||||
|
2022
Q4 | $71M | Sell |
|
|||||
|
2022
Q3 | $63.8M | Sell |
|
|||||
|
2022
Q2 | $299M | Sell |
|
|||||
|
2022
Q1 | $585M | Buy |
|
|||||
|
2021
Q4 | $460M | Sell |
|
|||||
|
2021
Q3 | $447M | Sell |
|
|||||
|
2021
Q2 | $462M | Sell |
|
|||||
|
2021
Q1 | $624M | Sell |
|
|||||
|
2020
Q4 | $1.01B | Sell |
|
|||||
|
2020
Q3 | $798M | Sell |
|
|||||
|
2020
Q2 | $832M | Buy |
|
|||||
|
2020
Q1 | $572M | Sell |
|
|||||
|
2019
Q4 | $950M | Buy |
|
|||||
|
2019
Q3 | $879M | Buy |
|
|||||
|
2019
Q2 | $876M | Buy |
|
|||||
|
2019
Q1 | $535M | Buy |
|
|||||
|
2018
Q4 | $441M | Buy |
|
|||||
|
2018
Q3 | $476M | Sell |
|
|||||
|
2018
Q2 | $461M | Sell |
|
|||||
|
2018
Q1 | $419M | Buy |
|
|||||
|
2017
Q4 | $323M | Sell |
|
|||||
|
2017
Q3 | $358M | Sell |
|
|||||
|
2017
Q2 | $388M | Sell |
|
|||||
|
2017
Q1 | $624M | Sell |
|
|||||
|
2016
Q4 | $519M | Sell |
|
|||||
|
2016
Q3 | $512M | Buy |
|
|||||
|
2016
Q2 | $421M | Sell |
|
|||||
|
2016
Q1 | $376M | Sell |
|
|||||
|
2015
Q4 | $600M | Sell |
|
|||||
|
2015
Q3 | $637M | Sell |
|
|||||
|
2015
Q2 | $555M | Buy |
|
|||||
|
2015
Q1 | $662M | Sell |
|
|||||
|
2014
Q4 | $659M | Sell |
|
|||||
|
2014
Q3 | $698M | Sell |
|
|||||
|
2014
Q2 | $1.03B | Sell |
|
|||||
|
2014
Q1 | $1.01B | Sell |
|
|||||
|
2013
Q4 | $899M | Sell |
|
|||||
|
2013
Q3 | $857M | Sell |
|
|||||
|
2013
Q2 | $785M | Buy |
|